glp 1 and heart failure Impact of GLP-1 receptor agonists on cardiovascular outcomes in with preserved ejection fraction (HFpEF): systematic review meta-analysis | Clinical Research in Cardiology Treatment of High-Risk Patients with

During those trials, researchers noticed that many patients were losing a meaningful amount of weight even when weight loss was not the main goal

Heart Failure 6 (3), 395402

Your PCP, endocrinologist, dietitian, and pharmacist are all in the same system, looking at the same chart

Zheng Y, Zhang Z, Tang P, Wu Y, Zhang A, Li D, et al

Tirzepatide may be an excellent option for adults who: Have struggled with weight loss despite diet and exercise Experience weight-related health concerns Prefer a medically supervised approach Want a treatment that supports both appetite and metabolism A consultation is required to ensure Tirzepatide is safe and appropriate based on your health history and goals

PMID: 191 IwaniecUTYuanDPowerRAWronskiTJ